Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Epoch Biodesign

Request full access

Designing and scaling the first enzymes capable of transforming plastics into low-carbon, circular chemicals

London, United KingdomFounded 2019Biotech & Life Sciences

About Epoch Biodesign

Epoch Biodesign is a London deep-tech company that designs AI-discovered enzymes to break down and recycle plastics and textiles, including nylon 6,6, into circular chemicals at commercial scale. In March 2026 it closed a $12 million / about €10.3 million strategic funding round with lululemon, KOMPAS VC, Happiness Capital, Extantia, Leitmotif and others, bringing total capital raised to over $50 million to commercialise enzymatic nylon recycling and build a London demonstration facility (following an earlier Series A). Sources: Tech.eu 25 March 2026; EU-Startups; TechCrunch.

Source: Dealroom company data

At a glance

Status
Operational
Employees
57
Open positions
2
Dealroom signal
91.2/100
Industry
Health
Sub-industry
BioTechnology
Sector
Recycling, Biotechnology, Synthetic Biology, Sustainable Development Goals, Advanced Materials, Climate Tech, Circular Economy, BIA Techbio UK
Technology
Hardware, Deep Tech
Business model
Manufacturing
Client focus
B2B

Open roles

1 open role
RoleTeamLocationPosted
Fiber and Polymer LeadThe London Metal Exchange, UK +14d ago
From job postings in the last four months. Careers page ↗More startups hiring →

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Mar 2026 $12M $92M Lululemon · Extantia Capital · KOMPAS VC · Happiness Capital ↗
GRANT✓Other financing Mar 2025 $1M — Government of the United Kingdom ↗
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Epoch Biodesign website traffic

Latest recorded traffic for Epoch Biodesign is 5.1K monthly website visits, up 6.3% over the last three months. Epoch Biodesign's team grew 14% over the past year.

Latest monthly visits5.1K 3-month web change+6.3% 1-year team growth+14%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Epoch Biodesign in the London ecosystem

Live from Dealroom

The Epoch Biodesign office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

23 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed10 investors entered at this stage

Series A8 investors entered at this stage

  • Extantia Capital
  • Inditex
  • Happiness Capital
  • Kibo Invest
  • Day One Ventures
  • Lululemon
  • KOMPAS VC
  • Leitmotif

Other known investors5 additional known investors

  • Cambridge Angels
  • Matthew Claxton
  • Net Zero Technology Centre
  • Planet Fund
  • Possible Ventures
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Epoch Biodesign’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.